Related Experiment Video
Updated: Jul 9, 2025

A Multiplexed Luciferase-based Screening Platform for Interrogating Cancer-associated Signal Transduction in Cultured Cells
Published on: July 3, 2013
KRAS and MT-CO1 genes in colorectal cancer: a molecular investigation
Harmand A Hama1, Bestoon S Hasan2, Basak Barzngy3
1Department of Biology, Faculty of Education, Tishk International University, Erbil, Kurdistan Region of Iraq. harmand.ali@tiu.edu.iq.
Abstract:
Colorectal cancer (CRC) is the third leading cause of cancer-related deaths worldwide. The tumor suppressor gene MT-CO1, and Kristen Rat Sarcoma Virus (KRAS), an oncogene are primarily responsible for controlling cell apoptosis, cell cycle arrest, and cell proliferation, and any irregularities in these genes could lead to cancer. This study aims to examine the expression of KRAS and MT-CO1 in CRC biopsy specimens and investigate their relationship with one another in CRC patients residing in the Erbil city of Kurdistan Region, Iraq. The study involved categorizing 42 sets of colorectal cancer tissues and their corresponding controls based on their types and patients' clinical characteristics. The expression of KRAS and MT-CO1 in the samples was assessed using Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR), with statistical significance set at p<0.05. The expression of KRAS was found to be significantly higher in CRC compared to the control (n=42, p=0.0001). On the other hand, the expression of MT-CO1 did not exhibit significant differences compared to the control group with a p-value of 0.12. Furthermore, the Chi-square and correlation analysis results depicted that MT-CO1 expression negatively correlates with KRAS expression (p= 0.0001, r= -0.047) in CRC tissues. In conclusion, the variation in the expression of KRAS and MT-CO1, and their correlations could potentially serve as a good indicator in the detection and prognosis of CRC, which might lead to better translational research on the same. However, for a better understanding of the underlying mechanisms, further analysis is required.
Insights
This study found elevated KRAS oncogene expression in colorectal cancer (CRC) tissues, while MT-CO1 tumor suppressor gene expression showed no significant difference. A negative correlation was observed between MT-CO1 and KRAS in CRC.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Colorectal cancer (CRC) is a leading cause of cancer mortality globally.
- The tumor suppressor gene MT-CO1 and the oncogene KRAS play critical roles in cell regulation.
- Dysregulation of MT-CO1 and KRAS is implicated in cancer development.
Purpose of the Study:
- To investigate the expression levels of KRAS and MT-CO1 in colorectal cancer (CRC) biopsy specimens.
- To explore the relationship between KRAS and MT-CO1 expression in CRC patients.
- To assess the potential of these genes as biomarkers for CRC detection and prognosis.
Main Methods:
- Analysis of 42 colorectal cancer tissue samples and corresponding controls.
- Assessment of KRAS and MT-CO1 gene expression using Reverse Transcriptase-Polymerase Chain Reaction (RT-PCR).
- Statistical analysis including Chi-square and correlation tests (p<0.05).
Main Results:
- KRAS expression was significantly upregulated in CRC tissues compared to controls (p=0.0001).
- MT-CO1 expression did not show a significant difference between CRC tissues and controls (p=0.12).
- A significant negative correlation was found between MT-CO1 and KRAS expression in CRC tissues (p=0.0001, r=-0.047).
Conclusions:
- Variations in KRAS and MT-CO1 expression and their correlation may serve as indicators for CRC detection and prognosis.
- Further research is needed to elucidate the underlying mechanisms of these gene interactions in CRC.
- These findings could contribute to advancements in translational research for colorectal cancer.
More Related Videos
08:12Detection of a Circulating MicroRNA Custom Panel in Patients with Metastatic Colorectal Cancer
Published on: March 14, 2019
09:29Development and Maintenance of a Preclinical Patient Derived Tumor Xenograft Model for the Investigation of Novel Anti-Cancer Therapies
Published on: September 30, 2016
Related Concept Videos
The Ras Gene
Ras is a...
Tumor Progression
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...